Stock News

Is Abbott Laboratories a Good Dividend Stock to Buy Now?
Abbott Laboratories (NYSE:ABT) Q4 2022 Earnings Call Transcript
FDA Approves Abbott's Spinal Cord Stimulation for People Living with Painful Diabetic Peripheral Neuropathy
Abbott's Sales and Earnings Are Sinking: Should Investors Worry?
Abbott Laboratories (ABT) Q4 2022 Earnings Call Transcript
US STOCKS-S&P 500 closes slightly red as weak corporate guidance fuels recession fears
US STOCKS-Wall Street dips as weak corporate guidance fuels recession fears
Abbott beats earnings, revenue expectations in Q4
UPDATE 4-Abbott's medical device sales hit by China curbs, supply chain issues

As seen on...